Advertisement
Advertisement

BLTE

BLTE logo

Belite Bio, Inc - ADR

56.28
USD
-1.00
-1.75%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

56.28

0.00
0.00%

Belite Bio, Inc - ADR Profile

About

Belite Bio Inc. is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration, such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease, and metabolic diseases. Belite Bio Inc. is based in SAN DIEGO.

Info & Links

CEO

Yu-Hsin Lin

Headquarters

12750 HIGH BLUFF DRIVE SUITE 475
SAN DIEGO, CA 92130, UNITED STATES

Sector

Medical

Auditor

Marcum Asia CPAs LLP

Share holders

--

Employees

25

Belite Bio, Inc - ADR Statistics

Valuation Measures

Market Capitalization2

1.82B

Enterprise Value

1.79B

Enterprise Value/EBITDA(ttm)

-44.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

15.62

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-31.94%

Return on Invested Capital(ttm)

-31.11%

Return on Assets(ttm)

-30.73%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-40.00M

Net Income Available to Common(ttm)

-36.14M

Diluted EPS(ttm)

-1.11

Share Statistics

Beta (5Y Monthly)

-1.59

52-Week Change

74.08%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

31.83M

Dividend Yield

0.00%

Float4

27.61M

% Held by Insiders

13.29%

% Held by Institutions

0.53%

Balance Sheet

Total Cash(mrq)

145.15M

Total Cash Per Share(mrq)

4.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

24.31%

Quick Ratio(mrq)

30.73%

Book Value Per Share(mrq)

4.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.96

Free Cash Flow(ytd)

-29.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement